|
MechanismVEGF-A inhibitors |
|
|
|
|
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.United States |
First Approval Date17 Sep 2004 |
100 Clinical Results associated with PharmaSwiss Ceská Republika sro
0 Patents (Medical) associated with PharmaSwiss Ceská Republika sro
100 Deals associated with PharmaSwiss Ceská Republika sro
100 Translational Medicine associated with PharmaSwiss Ceská Republika sro